VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Atlas Copco AB (publ) vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Atlas Copco AB (publ)
ATCO-A · Nasdaq Stockholm
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Atlas Copco AB (publ)'s moat claims, evidence, and risks.
View ATCO-A analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 63 / 100 for Atlas Copco AB (publ)).
- Segment focus: Atlas Copco AB (publ) has 4 segments (43.8% in Compressor Technique); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Atlas Copco AB (publ) has 6 moat types across 2 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Atlas Copco AB (publ)
Compressor Technique
Industrial compressors, air/gas systems (including air treatment) and related aftermarket service
Global
Industrial and process customers; distributors; service-contract customers
Equipment OEM + aftermarket service provider
43.8%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Atlas Copco AB (publ) strengths
Novo Nordisk A/S strengths
Segment mix
Atlas Copco AB (publ) segments
Full profile >Compressor Technique
Oligopoly
Vacuum Technique
Oligopoly
Industrial Technique
Oligopoly
Power Technique
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.